{"DataElement":{"publicId":"6180821","version":"1","preferredName":"Oropharyngeal p16-Negative Cancer AJCC Edition 8 Pathologic Distant Metastasis M Category","preferredDefinition":"Extent of the distant metastasis for p16-negative oropharyngeal carcinoma based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.","longName":"OX16N_AJC8_PTH_M_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6052661","version":"1","preferredName":"Oropharynx Neoplasm CDKN2A-p16 Negative Pathologic M Category","preferredDefinition":"The part of the pharynx between the soft palate and the upper portion of the epiglottis._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Indicates that expression of the p16 form of CDKN2A has not been detected in a sample._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. M refers to the presence of metastasis.","longName":"6052651v1.0:6072200v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6052651","version":"1","preferredName":"Oropharynx Neoplasm","preferredDefinition":"The part of the pharynx between the soft palate and the upper portion of the epiglottis.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12762:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharynx","conceptCode":"C12762","definition":"The part of the pharynx between the soft palate and the upper portion of the epiglottis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630C1054-6248-5BD4-E053-F662850A4B08","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6072200","version":"1","preferredName":"CDKN2A-p16 Negative Pathologic M Stage","preferredDefinition":"Indicates that expression of the p16 form of CDKN2A has not been detected in a sample.:Caused by or altered by or manifesting disease or pathology.:One criteria of the TNM staging system.  M refers to the presence of metastasis.","longName":"C132226:C25610:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A-p16 Negative","conceptCode":"C132226","definition":"Indicates that expression of the p16 form of CDKN2A has not been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6541DCD1-4014-7A2B-E053-F662850A62F0","latestVersionIndicator":"Yes","beginDate":"2018-02-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-15","modifiedBy":"ONEDATA","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"630C2564-13CC-5DC2-E053-F662850AE62E","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"TAYLORT","dateModified":"2018-04-09","changeDescription":"4/9/18 tt released. 1/18/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6052708","version":"1","preferredName":"Oropharyngeal (p16-Negative) Carcinoma American Joint Committee on Cancer Edition 8 M Category","preferredDefinition":"A finding about one or more characteristics of p16-negative oropharyngeal cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to p16-negative squamous cell carcinomas of the oropharynx, oropharyngeal cancers without p16 immunostaining performed, minor salivary gland carcinomas of the oropharynx, and neuroendocrine carcinomas of the oropharynx. Oropharyngeal cancers which are p16-positive are staged according to the classification for p16-positive oropharyngeal cancers. (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system.  M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.","longName":"6052708v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pM1","valueDescription":"Oropharyngeal (p16-Negative) Cancer pM1 TNM Finding v8","ValueMeaning":{"publicId":"6052710","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer pM1 TNM Finding v8","longName":"6052710","preferredDefinition":"Oropharyngeal (p16-negative) cancer with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer pM1 TNM Finding v8","conceptCode":"C132987","definition":"Oropharyngeal (p16-negative) cancer with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630DF8B7-31D4-3D3B-E053-F662850AB67C","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"630DF8B7-31ED-3D3B-E053-F662850AB67C","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","deletedIndicator":"No"},{"value":"cM0","valueDescription":"Oropharyngeal (p16-Negative) Cancer cM0 TNM Finding v8","ValueMeaning":{"publicId":"6052714","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer cM0 TNM Finding v8","longName":"6052714","preferredDefinition":"Oropharyngeal (p16-negative) cancer without evidence of distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer cM0 TNM Finding v8","conceptCode":"C132983","definition":"Oropharyngeal (p16-negative) cancer without evidence of distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630DF8B7-3220-3D3B-E053-F662850AB67C","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"630DF8B7-3239-3D3B-E053-F662850AB67C","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","deletedIndicator":"No"},{"value":"cM1","valueDescription":"Oropharyngeal (p16-Negative) Cancer cM1 TNM Finding v8","ValueMeaning":{"publicId":"6052712","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer cM1 TNM Finding v8","longName":"6052712","preferredDefinition":"Oropharyngeal (p16-negative) cancer with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer cM1 TNM Finding v8","conceptCode":"C132984","definition":"Oropharyngeal (p16-negative) cancer with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630DF8B7-31FA-3D3B-E053-F662850AB67C","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"630DF8B7-3213-3D3B-E053-F662850AB67C","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6052707","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer TNM Finding v8 American Joint Committee on Cancer M Category Category","preferredDefinition":"A finding about one or more characteristics of p16-negative oropharyngeal cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to p16-negative squamous cell carcinomas of the oropharynx, oropharyngeal cancers without p16 immunostaining performed, minor salivary gland carcinomas of the oropharynx, and neuroendocrine carcinomas of the oropharynx. Oropharyngeal cancers which are p16-positive are staged according to the classification for p16-positive oropharyngeal cancers. (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system.  M refers to the presence of metastasis.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C132909:C39315:C25727:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer TNM Finding v8","conceptCode":"C132909","definition":"A finding about one or more characteristics of p16-negative oropharyngeal cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to p16-negative squamous cell carcinomas of the oropharynx, oropharyngeal cancers without p16 immunostaining performed, minor salivary gland carcinomas of the oropharynx, and neuroendocrine carcinomas of the oropharynx. Oropharyngeal cancers which are p16-positive are staged according to the classification for p16-positive oropharyngeal cancers. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630DF8B7-31A8-3D3B-E053-F662850AB67C","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"630DF8B7-31B9-3D3B-E053-F662850AB67C","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"TAYLORT","dateModified":"2018-04-09","changeDescription":"4/9/18 tt released. 1/18/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5280817","version":"1","longName":"UWI2016-07-01","context":"DCP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6052641","version":"1","longName":"Oropharyngeal","context":"NCI Standards"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Pathologic M category","type":"Preferred Question Text","description":"Pathologic M category","url":null,"context":"NCI Standards"},{"name":"DCP Text-1","type":"Alternate Question Text","description":"p16-: Metastasis (V8)","url":null,"context":"DCP"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"696B3B26-3083-419D-E053-F662850A89AB","latestVersionIndicator":"Yes","beginDate":"2018-04-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-09","modifiedBy":"KNABLEJ","dateModified":"2020-01-14","changeDescription":"4/9/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}